Clinical Trials Browser

Phase 3 × HER2 Positive Early Breast Cancer × pertuzumab × Clear all

NCT05883852 2023-06-27

EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer

Phase 3 Recruiting

HER2 Positive Early Breast Cancer